Proposed changes are open to public comment until April 11th.

Changes center around improving the assessment of mental and behavioral impairment.

AMA hopes to shift from a crisis-reaction framework to a more holistic model that prevents overdose while helping pain patients receive care.

The AMA suggests that prescription medications are no longer a significant factor in the opioid epidemic, and that opioid prescription limits should change.

Prescribing has doubled since 2003, overdose deaths quadrupled since 1996, and misuse accounts for 20% of benzodiazepine use.

A new JAMA study finds that increased county-level opioid marketing was tied to elevated overdose mortality.

An analysis of 90,000 private claims explores the relationship between early PT and reduced long-term opioid use in musculoskeletal pain.

A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.

In a randomized clinical trial of 460 patients, researchers found the treatment to have similar impact on self-rated disability as standard wound dressing.